Search research articles
Contact Us
Filters
Showing results (131-140 of 184) with videos related to
Page
of 19
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 4, 2023
MyPathway Human Epidermal Growth Factor Receptor 2 Basket Study: Pertuzumab + Trastuzumab Treatment of a Tissue-Agnostic Cohort of Patients With Human Epidermal Growth Factor Receptor 2-Altered Advanced Solid Tumors
Christopher J Sweeney, John D Hainsworth, Ron Bose, et al.
Surgical Endoscopy
|
January 23, 2026
RedoPOEM: efficacy and safety after failure of a first POEM for esophageal motility disorders
Amaury D'Angelo, Mathieu Pioche, Maximilien Barret, et al.
Frontiers in Public Health
|
June 10, 2022
A Restructured Hospital Into a One-Building Organization for COVID-19 Patients: A Resilient and Effective Response to the Pandemic
Simon Bessis, Aurélien Dinh, Sylvain Gautier, et al.
The Lancet. Oncology
|
August 2, 2021
Pertuzumab and trastuzumab for HER2-positive, metastatic biliary tract cancer (MyPathway): a multicentre, open-label, phase 2a, multiple basket study
Milind Javle, Mitesh J Borad, Nilofer S Azad, et al.
Endoscopy
|
October 21, 2016
A novel hemostatic powder for upper gastrointestinal bleeding: a multicenter study (the "GRAPHE" registry)
Sami Haddara, Jeremie Jacques, Stéphane Lecleire, et al.
Clinical Genetics
|
October 12, 2022
Delineation of the clinical profile of CNOT2 haploinsufficiency and overview of the IDNADFS phenotype
Marcello Niceta, Simone Pizzi, Francesca Inzana, et al.
Biorxiv : the Preprint Server for Biology
|
November 28, 2023
Proteome-wide base editor screens to assess phosphorylation site functionality in high-throughput
Patrick H Kennedy, Amin Alborzian Deh Sheikh, Matthew Balakar, et al.
Nature Methods
|
April 29, 2024
Post-translational modification-centric base editor screens to assess phosphorylation site functionality in high throughput
Patrick H Kennedy, Amin Alborzian Deh Sheikh, Matthew Balakar, et al.
Genes
|
June 28, 2023
Clinical Heterogeneity and Different Phenotypes in Patients with <i>SETD2</i> Variants: 18 New Patients and Review of the Literature
Alejandro Parra, Rachel Rabin, John Pappas, et al.
The Lancet. Haematology
|
March 22, 2026
Oral deucrictibant for prophylaxis of hereditary angioedema attacks (CHAPTER-1): primary analysis of a randomised, double-blind, placebo-controlled, phase 2 trial
Emel Aygören-Pürsün, Marcin Stobiecki, Anna Valerieva, et al.
Page
of 19
Search research articles
Search
Showing results (131-140 of 184) with videos related to
Sort By:
Page
of 19
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 4, 2023
MyPathway Human Epidermal Growth Factor Receptor 2 Basket Study: Pertuzumab + Trastuzumab Treatment of a Tissue-Agnostic Cohort of Patients With Human Epidermal Growth Factor Receptor 2-Altered Advanced Solid Tumors
Christopher J Sweeney, John D Hainsworth, Ron Bose, et al.
Surgical Endoscopy
|
January 23, 2026
RedoPOEM: efficacy and safety after failure of a first POEM for esophageal motility disorders
Amaury D'Angelo, Mathieu Pioche, Maximilien Barret, et al.
Frontiers in Public Health
|
June 10, 2022
A Restructured Hospital Into a One-Building Organization for COVID-19 Patients: A Resilient and Effective Response to the Pandemic
Simon Bessis, Aurélien Dinh, Sylvain Gautier, et al.
The Lancet. Oncology
|
August 2, 2021
Pertuzumab and trastuzumab for HER2-positive, metastatic biliary tract cancer (MyPathway): a multicentre, open-label, phase 2a, multiple basket study
Milind Javle, Mitesh J Borad, Nilofer S Azad, et al.
Endoscopy
|
October 21, 2016
A novel hemostatic powder for upper gastrointestinal bleeding: a multicenter study (the "GRAPHE" registry)
Sami Haddara, Jeremie Jacques, Stéphane Lecleire, et al.
Clinical Genetics
|
October 12, 2022
Delineation of the clinical profile of CNOT2 haploinsufficiency and overview of the IDNADFS phenotype
Marcello Niceta, Simone Pizzi, Francesca Inzana, et al.
Biorxiv : the Preprint Server for Biology
|
November 28, 2023
Proteome-wide base editor screens to assess phosphorylation site functionality in high-throughput
Patrick H Kennedy, Amin Alborzian Deh Sheikh, Matthew Balakar, et al.
Nature Methods
|
April 29, 2024
Post-translational modification-centric base editor screens to assess phosphorylation site functionality in high throughput
Patrick H Kennedy, Amin Alborzian Deh Sheikh, Matthew Balakar, et al.
Genes
|
June 28, 2023
Clinical Heterogeneity and Different Phenotypes in Patients with <i>SETD2</i> Variants: 18 New Patients and Review of the Literature
Alejandro Parra, Rachel Rabin, John Pappas, et al.
The Lancet. Haematology
|
March 22, 2026
Oral deucrictibant for prophylaxis of hereditary angioedema attacks (CHAPTER-1): primary analysis of a randomised, double-blind, placebo-controlled, phase 2 trial
Emel Aygören-Pürsün, Marcin Stobiecki, Anna Valerieva, et al.
Page
of 19